Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
aceruloplasminemia
adverse drug reaction
agitation
akathisia
alemtuzumab
anemia
anemia, iron deficiency
aspartate aminotransferase
aspergillosis
asterixis
autoimmune disease
B 12 deficiency
Babinski sign
basophilic stippling of red blood cells
blood transfusion
bone marrow biopsy
bone marrow infarction
bone marrow necrosis
bone pain
carbamazepine
carcinoma
carcinoma of lung
carotid artery disease
CAT scan, abdomen
CAT scan, chest
celiac disease, adult
cerebral embolism
cerebral ischemia
cerebrovascular accident
ceruloplasmin, serum
cirrhosis
Clinical Pathologic Conference(C.P.C.)
clonazepam
coma
complications
compression fracture
confusion
copper deficiency
cough
deep gray nuclei
dementia
diabetes mellitus
diagnostic criteria
disability, neurological
disorientation
disseminated intravascular coagulation(DIC)
diurnal variation
dopamine agonist
dyspnea
ecchymoses
electrical fields, alternating
embolism
embolism, fat
encephalopathy
encephalopathy, Hashimoto's
familial
fatigue
ferritin, elevated
ferritinemia
fever
gabapentin
gastrointestinal disease, neurologic complications
gene mutation
genetic neurologic disorders
genetic testing
gluten-free diet
handwriting
headache
hemochromatosis
hemoglobin abnormality, neurologic complications of
hemophagocytic lymphohistiocytosis
hemophagocytosis
hepatic encephalopathy
hepatic failure
hepatitis C virus
heralding manifestation
hyperactivity
hypertriglyceridemia
hypofibrinogenemia
hypoglycorrhachia
hypoxia
iatrogenic neurologic disorders
immunosuppression
infection
infusion-associated reaction
intestinal biopsy
iron, brain
iron, serum
iron, serum, elevated
iron, serum, low
lactic dehydrogenase(LDH)
leukoencephalopathy
level of consciousness, decreased
liver biopsy
liver disease
liver function enzymes
liver nodules
liver scan
lung nodule
lymphadenopathy
lymphadenopathy, hilar
malabsorption
malabsorption syndrome
mental status, abnormal
misdiagnosis
mortality
MRI, abnormal
MRI, diffusion weighted
MRI, gradient-echo
MRI, paramagnetic effect
MRI, starfield pattern
MRI, susceptibility weighted
multiple sclerosis
multiple sclerosis, treatment of
neoplastic angioendotheliosis
neuroleptic malignant syndrome
neurologic complications of, systemic cancer
neurologic complications of, systemic disease
neurologic disease, diagnoses of
neurologic symptoms
night sweats
opiate
osteoporosis
pain
pain, abdominal
pain, back
pain, severe
pancytopenia
paranoia
paresthesias
petechiae
pramipexole
preclinical
pregnancy, neurologic complications in
prognosis
psychiatric disorder
psychiatric problems in neurologic disorders
psychosis
psychotic behavior
rash
respiratory failure
restless leg syndrome
retinopathy
review article
risk factors
rituximab
sedimentation rate, elevated
seizure
septicemia
serum lipase, elevated
sickle cell crisis
sickle cell disease
skin, biopsy
skin, lesions in neurologic disorders
soluble interlukin 2 receptor
splenomegaly
Still's disease
subcortical U fibers
systemic illness
thrombocytopenia
thyroiditis
tongue, petechiae
transglutaminase antibodies
treatment of neurologic disorder
unconsciousness
undiagnosed
viral infection
vitamin D deficiency
vitamin deficiency
weakness
weight loss
white matter disease
Showing articles 250 to 300 of 800 << Previous Next >>

High Titers of CA-125 May Be Associated weith Recurrent Ischemic Strokes in Patients with Cancer
Neurol 64:1944-1945, Jovin,T.G.,et al, 2005

Seizures Following Reduction in Phenytoin Level After Orally Administered Folic Acid
Neurol 64:1982, Steinweg,D.L.&Bentley,M.L., 2005

Hyperglycemic Hemianopia: A Reversible Complication of Non-Ketotic Hyperglycemia
Neurol 65:616-619, Lavin,P.J.M., 2005

MRI T2 Hypointensity of the Dentate Nucleus is Related to Ambulatory Impairment in Multiple Sclerosis
J Neurol Sci 234:17-24, Tjoa,C.W.,et al, 2005

Underappreciated Statin-Induced Myopathic Weakness Causes Disability
Neurorehabil Neural Repair 19:259-263, Dobkin,B.H., 2005

Mitoxantrone Treatment of Multiple Sclerosis
Neurol 63(Suppl 6):S28-S32, Cohen,B.A. &Mikol,D.D., 2004

Hyperhomocysteinemia, Low Folate and Vitamin B12 Concentrations, and Methylene Tetrahydrofolate Reductase Mutation in Cerebral Venous Thrombosis
Stroke 35:1790-1794, Cantu,C.,et al, 2004

Lowering Homocysteine in Patients with Ischemic Stroke to Prevent Recurrent Stroke, Myocardial Infarction, and Death
JAMA 291:565-575,621, Toole,J.F.,et al, 2004

The New Antiepileptic Drugs, Scientific Review
JAMA 291:605-614, LaRoche,S.M.&Helmers,S.L., 2004

Liver Injury Associated with the B-Interferons for MS
Neurol 62:628-631, Tremlett,H.L.,et al, 2004

Copper Deficiency Myelopathy
Arch Neurol 61:762-766, Kumar,N.,et al, 2004

B- and T-cell Markers in Opsoclonus-Myoclonus Syndrome
Neurol 62:1526-1532,1466, Pranzatelli,M.R.,et al, 2004

Predictors of Hyperacute Clinical Worsening in Ischemic Stroke Patients Receiving Thrombolytic Therapy
Stroke 35:1903-1907, Leigh,R.,et al, 2004

Reversible Hyperintensity Lesion on Diffusion-Weighted MRI in Hypoglycemic Coma
Neurol 63:392-393, Aoki,T.,et al, 2004

Unilateral Putaminal CT, MR, and Diffusion Abonromalities Secondary to Nonketotic Hyperglycemia in the Setting of Acute Neurologic Symptoms Mimicking Stroke
AJNR 25:975-976, Wintermark,M.,et al, 2004

Lower Phenytoin Serum Levels in Persons Switched from Brand to Generic Phenytoin
Neurol 63:1494-1496, Burkhardt,R.T.,et al, 2004

Lack of Improvement in Patients with Acute Stroke After Treatment with Thrombolytic Therapy
JAMA 292:1839-1844, Saposnik,G.,et al, 2004

Correlating Lamotrigine Serum Concentrations with Tolerability in Patients with Epilepsy
Neurol 63:1022-1026, Hirsch,L.J.,et al, 2004

The Metabolic Syndrome, Inflammation, and Risk of Cognitive Decline
JAMA 292:2237-2242, Yaffe,K.,et al, 2004

Amyloid Myopathy Presenting with Distal Atrophic Weakness
Muscle Nerve 29:605-609, Smestad, C.,et al, 2004

Acute Mycoplasma Pneumoniae Infection Presenting as Cholestatic Hepatitis
J Clin Microbiol 41:514-515, Grullich, C.,et al, 2003

Investigation of Risk Factors in Children with Arterial Ischemic Stroke
Ann Neurol 53:167-173,149, Ganesan,V.,et al, 2003

Treatment of Wilson Disease With Ammonium Tetrathiomolybdate, III. Initial Therapy in a Total of 55 Neurologically Affected Patients and Follow-up With Zinc Therapy
Arch Neurol 60:379-385, Brewer,G.J.,et al, 2003

Brain MR Imaging in Acute Hyperammonemic Encephalopathy Arising from Late-Onset Ornithine Transcarbamylase Deficiency
AJNR 24:390-393, Takanashi,J-i.,et al, 2003

POEMS Syndrome Associated with Ischemic Stroke
Arch Neurol 60:745-749, Kang, K.,et al, 2003

Effects of Admission Hyperglycemia on Stroke Outcome in Reperfused Tissue Plasminogen Activator-Treated Patients
Stroke 34:1235-1241, Alvarez-Sabin,J.,et al, 2003

Homocysteine and Risk of Recurrent Stroke
Stroke 34;1258-1261, Boysen,G.,et al, 2003

Restless Legs Syndrome
NEJM 348:2103-2109, Earley,C.J., 2003

Polymyositis and Dermatomyositis
Lancet 362:971-982, Dalakas,M.C.&Hohlfeld,R., 2003

Diagnostic Approach in Patients with Symmetric Imaging Lesions of the Deep Gray Nuclei
The Neurologist 9:250-261, Finelli,P.F.&DiMario,Jr,F.J., 2003

Randomized, Concentration-Controlled Trial of Topiramate in Refractory Focal Epilepsy
Neurol 61:1210-1218, Christensen,J.,et al, 2003

Hyperhomocysteinemia as an Independent Risk Factor for Silent Brain Infarction
Neurol 61:1595-1599, Kim,N.K.,et al, 2003

Stroke Prevention with the Oral Direct Thrombin Inhibitor Ximelagatran Compared with Warfarin in Patients with Non-Valvular Atrial Fibrillation (SPORTIF III): Randomised Controlled Trial
Lancet 362:1691-1698,1686, Executive Steering Committee on Behalf of the SPOR, 2003

Hyperhomocysteinemia in Cerebral Vein Thrombosis
Blood 102:1363-1366, Martinelli,I.,et al, 2003

Genetic, Clinical, and Radiographic Delineation of Hallervorden-Spatz Syndrome
NEJM 348:33-40, Hayflick,S.J.,et al, 2003

Hemichorea-Hemiballism in Primary Diabetic Patients: MR Correlation
J Comput Assist Tomogr 26:905-911, Lee,E.J.,et al, 2002

Disease-Modifying Therapy in Multiple Sclerosis: Strategies for Optimizing Management
The Neurologist 8:227-236, Frohman,E.,et al, 2002

Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
NEJM 346:476-483, 466, Seshadri,S.,et al, 2002

CSF Evaluation in Primary CNS Lymphoma Patients by PCR of the CDR III IgH Genes
Neurol 58:390-396,339, Gleissner,B.,et al, 2002

Clinicopath Conf, Bilateral, Diffuse Uveal Melanocytic Proliferation, Metastatic Endometrial Carcinoma
NEJM 346:189-195, Case 2-2002, 2002

Hyperhomocysteinemia and Other Inherited Prothrombotic Conditions in Young Adults With a History of Ischemic Stroke
Stroke 33:51-56, Madonna,P.,et al, 2002

Subtherapeutic Free Phenytoin Levels Following Fosphenytoin Therapy in Status Epilepticus
Neurol 58:147-148, Koul,R. &Deleu,D., 2002

Clinicopath Conf, Hyperviscosity Syndrome Due to IgG Multiple Myeloma
NEJM 346:603-610, Case 6-2002, 2002

Homocysteine, Silent Brain Infarcts, and White Matter Lesions: The Rotterdam Scan Study
Ann Neurol 51:285-289,279, Vermeer,S.E.,et al, 2002

Diffusion-Weighted and Gradient Echo Magnetic Resonance Findings of Hemichorea-Hemiballismus Associated with Diabetic Hyperglycemia
Arch Neurol 59:448-452, Chu,K.,et al, 2002

Spontaneous Cervical Artery Dissection
Stroke 33:657-658,664, Brandt,T. &Grond-Ginsbach,C., 2002

Stroke Prevention Therapy Beyond Antithrombotics: Unifying Mechanisms in Ischemic Stroke Pathogenesis and Implications for Therapy
Stroke 33:862-875, Gorelick,P.B., 2002

Symptoms of B12 Deficiency Can Occur in Women of Child Bearing Age Supplemented with Folate
Neurol 58:1572-1573, Drazkowski,J.,et al, 2002

Hyperammonemic Encephalopathy in Multiple Myeloma
NEJM 346:1674-1675, Kwan,L.,et al, 2002

Giant-cell Arteritis
NEJM 347:272-278, Case 23-2002, 2002



Showing articles 250 to 300 of 800 << Previous Next >>